Black Diamond Therapeutics
BDTX
BDTX
94 hedge funds and large institutions have $124M invested in Black Diamond Therapeutics in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
-6
Holders Change %
-6%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
20
Reduced
28
Closed
27
Calls
$87K
Puts
$260K
Net Calls
-$173K
Net Calls Change
+$99K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$2.05M |
| 2 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$1.1M |
| 3 |
BlackRock
New York
|
+$308K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$246K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$209K |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$6.43M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$4.44M |
| 3 |
SG Americas Securities
New York
|
-$2.29M |
| 4 |
HF
HRT Financial
New York
|
-$604K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$586K |
